Using Fenestrated Stent to Increase the Flow of Extracorporeal Membrane Oxygenation of Superior Vena Cava Compression Syndrome
- PMID: 37766775
- PMCID: PMC10521936
- DOI: 10.7759/cureus.46008
Using Fenestrated Stent to Increase the Flow of Extracorporeal Membrane Oxygenation of Superior Vena Cava Compression Syndrome
Abstract
Superior vena cava syndrome (SVCS) is an obstruction of the venous return through the superior vena cava (SVC) or any other significant branches. The obstruction may be external, like thoracic mass compressing the SVC, or internal, like thrombosis or tumor, which directly invades the SVC. Patients experiencing a medical emergency after being initially stabilized require treatment for SVCS, including endovenous recanalization and the implantation of an SVC stent to reduce the risk of abrupt respiratory arrest and death. A 54-year-old female presented from the university medical center with weight loss and solid food dysphagia for three months. Chest-CT scan showed a mediastinal mass of 10 x 9 x 8 cm. A transbronchial biopsy was attempted. The patient was arrested during the bronchoscopy lab procedure. Cardiopulmonary resuscitation (CPR) was initiated, and venoarterial-extracorporeal membrane oxygenation (VA-ECMO) was done through the right femoral artery cannula size 15 Fr due to the narrowing of the artery and the left femoral vein cannula size 23 Fr. During the night shift, the ECMO flow was hard to maintain with fluids, which was realized with the ECMO outflow volume issue. The next day, in the hybrid operating room, a fenestrated SVC stent was placed in the SVC, brachiocephalic, and internal jugular veins. The patient's hemodynamics improved post-stenting, especially ECMO outflow. This case illustrates that stenting in SVCS is a valid therapeutic option to increase the ECMO flow in this patient group.
Keywords: ecmo outflow due to svcs; endovascular stent therapy; fenestrated stent; increase flow of ecmo; mediastinal tumors; superior vena cava (svc) obstruction; superior vena cava (svc) syndrome; va-ecmo.
Copyright © 2023, Celik et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

Similar articles
-
Superior vena cava syndrome during veno-venous extracorporeal membrane oxygenation for COVID-19.Perfusion. 2021 Sep;36(6):630-633. doi: 10.1177/0267659120987973. Epub 2021 Jan 9. Perfusion. 2021. PMID: 33427042
-
Venovenous extracorporeal membrane oxygenation catheter related superior vena cava syndrome without pre-existing stenosis in an adult patient: a case report.BMC Pulm Med. 2025 Aug 6;25(1):375. doi: 10.1186/s12890-025-03851-2. BMC Pulm Med. 2025. PMID: 40770792 Free PMC article.
-
Superior vena cava drainage improves upper body oxygenation during veno-arterial extracorporeal membrane oxygenation in sheep.Crit Care. 2015 Feb 20;19(1):68. doi: 10.1186/s13054-015-0791-2. Crit Care. 2015. PMID: 25887895 Free PMC article.
-
Extracorporeal membrane oxygenation (ECMO) assisted huge mediastinal tumor resection combined with superior vena cava replacement: A case report and literature review.Perfusion. 2025 Apr;40(3):770-775. doi: 10.1177/02676591241251443. Epub 2024 Apr 29. Perfusion. 2025. PMID: 38680106 Review.
-
Superior Vena Cava Syndrome: An Umbrella Review.Cureus. 2023 Jul 20;15(7):e42227. doi: 10.7759/cureus.42227. eCollection 2023 Jul. Cureus. 2023. PMID: 37605686 Free PMC article. Review.
References
-
- Rapid fire: superior vena cava syndrome. Zimmerman S, Davis M. Emerg Med Clin North Am. 2018;36:577–584. - PubMed
-
- Superior vena cava syndrome: role of the interventionalist. Rachapalli V, Boucher LM. Can Assoc Radiol J. 2014;65:168–176. - PubMed
-
- Benign superior vena cava syndrome: stenting is now the first line of treatment. Rizvi AZ, Kalra M, Bjarnason H, Bower TC, Schleck C, Gloviczki P. J Vasc Surg. 2008;47:372–380. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous